Ching Yau Yi
Comptroller/Controller/Auditor en CHEMOCENTRYX, INC. .
Cargos activos de Ching Yau Yi
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CHEMOCENTRYX, INC. | Comptroller/Controller/Auditor | 06/06/2022 | - |
Historial de carrera de Ching Yau Yi
Antiguos cargos conocidos de Ching Yau Yi.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BRIDGEBIO PHARMA, INC. | Comptroller/Controller/Auditor | 07/10/2019 | 01/03/2022 |
NEKTAR THERAPEUTICS | Director of Finance/CFO | 01/05/2018 | 01/10/2019 |
THERAVANCE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2013 | 01/05/2018 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/2003 | 01/11/2013 |
Formación de Ching Yau Yi.
Nanyang Technological University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Singapur | 2 |
Operativa
Comptroller/Controller/Auditor | 3 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Sectorial
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ching Yau Yi
- Experiencia